10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2013 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 20, 2014) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Revenues | |||
| Premiums | $ 66,119,100 | 56,496,700 | 55,969,600 |
| Administrative fees | 4,031,900 | 3,934,100 | 3,854,600 |
| Other revenue | 40,400 | 83,200 | 41,000 |
| Total operating revenue | 70,191,400 | 60,514,000 | 59,865,200 |
| Net investment income | 659,100 | 686,100 | 703,700 |
| Net realized gains on investments | 271,900 | 334,900 | 235,100 |
| Other than temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (100,600) | (41,200) | (114,700) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 1,700 | 3,400 | 21,400 |
| Other-than-temporary impairment losses recognized in income | (98,900) | (37,800) | (93,300) |
| Total revenues | 71,023,500 | 61,497,200 | 60,710,700 |
| Expenses | |||
| Benefit expense | 56,237,100 | 48,213,600 | 47,647,500 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,526,900 | 1,586,900 | 1,616,800 |
| General and administrative expense | 8,426,000 | 7,093,600 | 6,818,800 |
| Total selling, general and administrative expense | 9,952,900 | 8,680,500 | 8,435,600 |
| Interest expense | 602,700 | 511,800 | 430,300 |
| Amortization of other intangible assets | 245,300 | 233,000 | 239,400 |
| Loss on extinguishment of debt | 145,300 | 0 | 0 |
| Total expenses | 67,183,300 | 57,638,900 | 56,752,800 |
| Income from continuing operations before income tax expense | 3,840,200 | 3,858,300 | 3,957,900 |
| Income tax expense | 1,205,900 | 1,207,300 | 1,311,200 |
| Income from continuing operations | 2,634,300 | 2,651,000 | 2,646,700 |
| (Loss) income from discontinued operations, net of tax | (144,600) | 4,500 | 0 |
| Net income | 2,489,700 | 2,655,500 | 2,646,700 |
| Basic net income (loss) per share: | |||
| Basic - continuing operations (in dollars per share) | 8.83 | 8.25 | 7.35 |
| Basic - discontinued operations (in dollars per share) | (0.49) | 0.01 | 0.00 |
| Basic net income per share | 8.34 | 8.26 | 7.35 |
| Diluted net income (loss) per share: | |||
| Diluted - continuing operations (in dollars per share) | 8.67 | 8.17 | 7.25 |
| Diluted - discontinued operations (in dollars per share) | (0.47) | 0.01 | 0.00 |
| Diluted net income per share | 8.20 | 8.18 | 7.25 |
| Dividends per share | 1.50 | 1.15 | 1.00 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |